Liraglutide

Authoritative sources

• Wikidata (Q416286)
• MeSH (D000068472)
• Wikipedia

Evidence base

• Systematic Review · 2025

  Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis

  Metabolism: clinical and experimental · Karakasis P, Patoulias D, Fragakis N, Mantzoros CS

• Meta-Analysis · 2025

  Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis

  Obesity reviews : an official journal of the International Association for the Study of Obesity · Berg S, Stickle H, Rose SJ, Nemec EC

• Randomized Controlled Trial · 2025

  Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial

  The New England journal of medicine · Fox CK, Barrientos-Pérez M, Bomberg EM, Dcruz J, et al.

• Systematic Review · 2025

  Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials

  Annals of internal medicine · Moiz A, Filion KB, Toutounchi H, Tsoukas MA, et al.

• Systematic Review · 2025

  Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA

  Obesity (Silver Spring, Md.) · Sinha B, Ghosal S

• Systematic Review · 2025

  A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults

  Nature medicine · McGowan B, Ciudin A, Baker JL, Busetto L, et al.

• Systematic Review · 2025

  Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic review

  Acta neuropsychiatrica · Au HCT, Zheng YJ, Le GH, Wong S, et al.

• Meta-Analysis · 2025

  Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients

  Journal of the American College of Cardiology · Galli M, Benenati S, Laudani C, Simeone B, et al.

• Meta-Analysis · 2024

  The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials

  Journal of diabetes and its complications · Austregésilo de Athayde De Hollanda Morais B, Martins Prizão V, de Moura de Souza M, Ximenes Mendes B, et al.

• Systematic Review · 2024

  The cost-effectiveness analysis of semaglutide for the treatment of adult and adolescent patients with overweight and obesity: a systematic review

  European journal of clinical pharmacology · Asiabar AS, Rezaei MA, Jafarzadeh D, Rajaei S, et al.

• Meta-Analysis · 2024

  Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis

  Obesity reviews : an official journal of the International Association for the Study of Obesity · Esparham A, Mehri A, Dalili A, Richards J, et al.

• Meta-Analysis · 2024

  Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · Ansari HUH, Qazi SU, Sajid F, Altaf Z, et al.

• Randomized Controlled Trial · 2023

  Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

  Cardiovascular diabetology · Sandsdal RM, Juhl CR, Jensen SBK, Lundgren JR, et al.

• Meta-Analysis · 2023

  Semaglutide and cancer: A systematic review and meta-analysis

  Diabetes & metabolic syndrome · Nagendra L, Bg H, Sharma M, Dutta D

• Randomized Controlled Trial · 2022

  Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial

  JAMA · Rubino DM, Greenway FL, Khalid U, O'Neil PM, et al.

• Randomized Controlled Trial · 2021

  Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined

  The New England journal of medicine · Lundgren JR, Janus C, Jensen SBK, Juhl CR, et al.

• Randomized Controlled Trial · 2021

  Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

  Lancet (London, England) · Lau DCW, Erichsen L, Francisco AM, Satylganova A, et al.

Where Liraglutide appears on Kindr Health